LaSalle St. Investment Advisors, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1966193 ELMHURST, IL

Position in RXRX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$249,560

New position

Shares Held

68,000

first reported quarter

Ownership

0.013%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#139

of 340 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LaSalle St. Investment Advisors, LLC holds $420,547 across 4 Biotechnology names. RXRX ranks #1 (59.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RXRX	Recursion Pharmaceuticals, Inc. This page	68,000	$249,560
2	HUMA	Humacyte, Inc.	113,869	$88,817
3	SANA	Sana Biotechnology, Inc.	22,000	$76,780
4	GTBP	GT Biopharma, Inc.	11,000	$5,390

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$249,560	68,000	—	Shares	Sole	2026-08-11
No filing history on record for this holder in this stock.